NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 5 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,876 | -44.1% | 20,400 | 0.0% | 0.00% | – |
| Q1 2023 | $6,936 | -0.9% | 20,400 | 0.0% | 0.00% | – |
| Q4 2022 | $7,000 | +133.3% | 20,400 | +155.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 8,000 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -70.0% | 8,000 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | 0.0% | 8,000 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -60.0% | 8,000 | -33.9% | 0.00% | – |
| Q3 2021 | $25,000 | +525.0% | 12,100 | +365.4% | 0.00% | – |
| Q2 2021 | $4,000 | -33.3% | 2,600 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | -40.0% | 2,600 | -38.1% | 0.00% | – |
| Q4 2020 | $10,000 | -16.7% | 4,200 | -16.0% | 0.00% | – |
| Q3 2020 | $12,000 | -71.4% | 5,000 | -58.0% | 0.00% | – |
| Q2 2020 | $42,000 | +250.0% | 11,900 | +138.0% | 0.00% | – |
| Q1 2020 | $12,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Citizens Financial Corp | 35,100 | $89,000 | 0.08% |
| Geier Asset Management, Inc. | 35,000 | $91,000 | 0.07% |
| Patriot Financial Group Insurance Agency, LLC | 43,250 | $107,000 | 0.03% |
| Willow Creek Wealth Management Inc. | 24,224 | $60,000 | 0.02% |
| WEBSTER BANK, N. A. | 70,000 | $174,000 | 0.02% |
| Brown Advisory Securities, LLC | 28,000 | $69,000 | 0.01% |
| Cubic Asset Management, LLC | 11,250 | $28,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 25,613 | $64,000 | 0.00% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $62,000 | 0.00% |
| Sterling Investment Advisors, Ltd. | 2,500 | $6,000 | 0.00% |